Chemforte India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.22 Cr
as on 16-11-2024
- Revenue 1003.21%
(FY 2023)
- Profit 11748.95%
(FY 2023)
- Ebitda 3702.41%
(FY 2023)
- Net Worth 5046.85%
(FY 2023)
- Total Assets 1478.95%
(FY 2023)
About Chemforte India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹10.22 Cr.
Abhishekkumar Modi, Talibraza Mahesaniya, Mohammadhaidar Sunasara, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100GJ2020PTC115964
- Company No.
115964
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chemforte India?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhishekkumar Modi | Director | 29-Aug-2020 | Current |
Talibraza Mahesaniya | Director | 03-Dec-2020 | Current |
Mohammadhaidar Sunasara | Director | 27-Nov-2021 | Current |
Bharatkumar Modi | Director | 15-Oct-2020 | Current |
Financial Performance of Chemforte India.
Chemforte India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1003.21% increase. The company also saw a substantial improvement in profitability, with a 11748.95% increase in profit. The company's net worth Soared by an impressive increase of 5046.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Chemforte India?
Unlock access to Chemforte India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Chemforte Drugs Private LimitedActive 1 year 6 months
Abhishekkumar Modi, Talibraza Mahesaniya and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 07 Jun 2023 | ₹2.22 M | Open |
Others Creation Date: 02 Aug 2022 | ₹10.00 Cr | Open |
How Many Employees Work at Chemforte India?
Chemforte India has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemforte India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemforte India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.